Education

• MD, Duke University School of Medicine, Durham, NC, 1992
• Residency, The Johns Hopkins Hospital, Baltimore, MD, 1992-1999
• Postdoctoral Research Fellowship, The Johns Hopkins Oncology Center, Baltimore, MD, 1994-1997
• Fellowship in Surgical Oncology and Endocrinology, The Johns Hopkins Hospital, Baltimore, MD, 1998-2000

Clinical Specialties

Dr. Chen is certified by the American Board of Surgery. He specializes in endocrine surgery (thyroid surgery, minimally invasive parathyroidectomy, and laparoscopic adrenalectomy); minimally invasive endocrine surgery, surgical oncology and adult general surgery.

Dr. Chen provides a wide range of services including Adrenal Surgery, Adrenalectomy, Laparoscopic, Adrenalectomy, Open, Central Neck Dissection, Endocrine Surgery, Fine Needle Aspiration (FNA), Minimally Invasive Parathyroidectomy, Minimally Invasive Radioguided Parathyroidectomy (MIRP), Modified Radical Neck Dissection, Parathyroid Surgery, Resection Of Substernal Goiter, Subtotal Parathyroidectomy, Thyroid Lobectomy, Thyroid Surgery, Thyroidectomy, and Total Thyroidectomy.

Research Interests

Dr. Chen is the leader of the endocrine cancer group at the University of Wisconsin Carbone Cancer Center. His research program investigates the development, progression, and treatment of endocrine tumors including gastrointestinal carcinoids, thyroid cancer, adrenal cancer, and pancreatic islet cell tumors.

Dr. Chen's Lab

Funding/Grants

• AAS Courses to Increase Women and Minorities in Academic Surgery
  Funding Agency: National Institutes of Health (NIH)
  Principal Investigator(s): Herbert Chen, MD
  More Information
• Co-delivery of siRNA and Anticancer Drug Using Multifunctional Au NR-based Nanocarriers for Targeted Neuroendocrine Cancer Therapy
  Funding Agency: UWCCC/Wisconsin Discovery Institute
  Principal Investigator(s): Herbert Chen, MD
  More Information
• GSK3β Signaling in Medullary Thyroid Cancer
  Funding Agency: National Institutes of Health
  Principal Investigator(s): Herbert Chen, MD
  More Information
• MEN2 Thyroid Cancer Professorship
  Funding Agency: American Cancer Society
  Principal Investigator(s): Herbert Chen, MD
  More Information
• Medullary Thyroid Carcinoma Surveillance Study: a Case Series Registry
  Funding Agency: Novo Nordisk
  Principal Investigator(s): Herbert Chen, MD
  More Information
• Modulating Raf-1 Signaling in Carcinoid Cancer
  Funding Agency: Carcinoid Cancer Foundation
  Principal Investigator(s): Herbert Chen, MD
  More Information
• Notch Signaling in Medullary Thyroid Cancer
  Funding Agency: American Cancer Society
  Principal Investigator(s): Herbert Chen, MD
  More Information
• Novel Nanomedicines for Targeted Neuroendocrine Cancer Therapy
  Funding Agency: UW Madison/Milwaukee
  Principal Investigator(s): Herbert Chen, MD
  More Information
• Surgery Clinical Research Experiences for High School Students
  Funding Agency: Doris Duke Charitable Foundation
  Principal Investigator(s): Herbert Chen, MD
  More Information
• Surgery Summer Experience for Medical Students
  Funding Agency: NIH/NIDDK
  Principal Investigator(s): Herbert Chen, MD
  More Information
• Surgery Summer Research Experience for Medical Students
  Funding Agency: National Institutes of Health
  Principal Investigator(s): Herbert Chen, MD, Bo Liu, PhD
  More Information
• Surgical Oncology Research Training Program
  Funding Agency: NIH/NCI
  Principal Investigator(s): Herbert Chen, MD
  More Information
• The Role of GSK3β in Carcinoid and Other Neuroendocrine Cancers
  Funding Agency: The Doctors Cancer Foundation
  Principal Investigator(s): Herbert Chen, MD
  More Information

Recent Publications

• Unilateral thyroidectomy for the treatment of benign multinodular goiter.
  Bauer PS, Murray S, Clark N, Pontes DS, Sippel RS, Chen H
  J. Surg. Res. 2013 May 11.
  [PubMed ID: 23688788]
  More Information
• A short-stay unit for thyroidectomy patients increases discharge efficiency.
  Vrabec S, Oltmann SC, Clark N, Chen H, Sippel RS
  J. Surg. Res. 2013 May 9.
  [PubMed ID: 23688791]
  More Information
• Significance of rebounding parathyroid hormone levels during parathyroidectomy.
  Schneider DF, Ojomo KA, Mazeh H, Oltmann SC, Sippel RS, Chen H
  J. Surg. Res. 2013 May 3.
  [PubMed ID: 23669749]
  More Information
• Doing away with the rule of 10 %.
  Oltmann SC, Chen H
  Ann. Surg. Oncol. 2013 May; 20(5):1403-4.
  [PubMed ID: 23504124]
  More Information
• Consensus Guidelines for the Management and Treatment of Neuroendocrine Tumors.
  Kunz PL, Reidy-Lagunes D, Anthony LB, Bertino EM, Brendtro K, Chan JA, Chen H, Jensen RT, Kim MK, Klimstra DS, Kulke MH, Liu EH, Metz DC, Phan AT, Sippel RS, Strosberg JR, Yao JC
  Pancreas 2013 May; 42(4):557-577.
  [PubMed ID: 23591432]
  More Information